Fuzhou Neurodawn Rongkang Pharmaceutical Co., Ltd

This study is testing a new treatment called RK-4 for people who have just had a severe, large stroke and cannot receive or do not respond to standard clot-busting treatments. Researchers will inject RK-4 directly into the skull bone marrow over three days to see if it is safe an…